Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
about
Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end productsRole of Galectin-3 in Obesity and Impaired Glucose HomeostasisA systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new normsPrinciples of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in diseaseThe role of collagen crosslinks in ageing and diabetes - the good, the bad, and the uglyRole of plasma kallikrein in diabetes and metabolismStereospecific mechanism of DJ-1 glyoxalases inferred from their hemithioacetal-containing crystal structuresDiabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary DysfunctionTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsImmunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitusIncreased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbiditycAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-productsTIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand bindingDiabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationEffect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide.Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.Effect of cranberry (Vaccinium macrocarpon) oligosaccharides on the formation of advanced glycation end-products.Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.Salivary peptidome in type 1 diabetes mellitus.A novel cellular defect in diabetes: membrane repair failure.Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signalingTriple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypesDeterminants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancerAngiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs.Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ miceExpression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions.Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.Epigenetic mechanisms in diabetic vascular complications.Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities studyMorphological Changes and Immunohistochemical Expression of RAGE and its Ligands in the Sciatic Nerve of Hyperglycemic Pig (Sus Scrofa)Diabetes and cancer: Looking at the multiligand/RAGE axis.Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.RAGE, receptor of advanced glycation endoproducts, negatively regulates chondrocytes differentiationAdvanced glycation end-products reduce collagen molecular sliding to affect collagen fibril damage mechanisms but not stiffnessAssociation of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.Adaptive evolution of the MHC class III-encoded receptor RAGE in primates and murine rodents.
P2860
Q24643454-15BD9919-A40A-4419-A1E5-6F3D2CEDB0B8Q26771826-29786CEF-196D-43E2-89AE-CD3D18EA07A0Q26827439-74389A0C-34BC-40A4-9A40-73041014BC81Q26859449-D0AC65D4-0243-4575-B0A7-DB5FEE8DFFD9Q26864529-B982ACA1-F617-439C-A718-F61EA9F6A873Q27016431-1C346D94-EF07-4C81-B6FA-6DA8690362D2Q27695678-3A2E0D6B-B8BA-4405-BF9E-3E461C6C834FQ28072462-79FD8D22-0308-48D8-BFF4-317C7BE1BB40Q28085089-19093A60-1DBC-4784-9A0E-46672D208227Q28254386-08322D3F-65A8-4C49-917B-8018A1FB2F3CQ28269188-39310C5C-220F-4967-8FF5-001B2E836F26Q28383076-3E557990-900D-42EA-9165-A36925CA18E5Q28587417-1979DE7A-F754-446B-AC7A-85F0CA11A501Q28741936-E28EFCD1-D8C1-46F5-9BCD-BA3CEC07FDBAQ30433016-3AB892A1-8B07-4194-8E0C-BF4679EAF08BQ33415190-805D7541-877D-4593-9414-3F7D8FE50E65Q33623473-C02F4CAE-5364-4443-859F-3C04287E3347Q33711306-82F0E6B1-4686-46AE-9E23-88E03FA9E003Q33751565-F6CAA135-4E84-457A-9303-9554464BF61EQ33787882-839D8E22-CF7E-40F8-8601-D4BCF2A96B87Q33928779-AF1560FD-5585-4251-800B-75D25F7A0E09Q34013080-0CE3E92C-51C5-4C16-85EF-29C8170F5A4EQ34028243-90E15125-66BA-4F5B-9F4C-1445C8DDDE82Q34056610-907ABD09-19ED-4425-A0E8-EDCE5C18EDB8Q34221728-AF470AFD-54DD-4074-B104-4DAA5EC816BDQ34426525-9097DA73-8D6C-47F5-91E3-AC842DB83A70Q34441960-31005904-815C-4705-8117-2F1E44806EF7Q34442201-B486402D-004A-4F4C-807D-9AAA3290955BQ34513915-5265DB5C-A852-4A31-A177-C9C9E0C9D5E6Q34647622-07A146B8-CA40-4D9C-8405-9C5191BB8F9CQ34776889-39195E6D-501E-4777-8737-86822FA377B6Q34986508-7BEE8961-6F59-48AE-951A-3F14CBFCF2DEQ35152739-D1121CCD-C181-4E3E-AA6D-08BEF25CDE6EQ35165597-AB5EC03F-11D5-43DB-AE44-A0FBE303A07AQ35172873-E42079B2-F083-42CE-A635-E44C6EBB098DQ35228483-25D35865-B6A4-445C-9033-9436352CD0B7Q35294412-7FCB325E-31F6-42E3-85DF-579A4B00E755Q35386964-F00704E7-1D37-453E-99BF-CDA1AFC99050Q35545467-B31F8BD7-C544-4574-A888-8B1380C6FC09Q35780980-B7027528-291F-4DF4-83B0-8805B727BB96
P2860
Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of disease: advance ...... on and diabetes complications.
@en
Mechanisms of disease: advance ...... on and diabetes complications.
@nl
type
label
Mechanisms of disease: advance ...... on and diabetes complications.
@en
Mechanisms of disease: advance ...... on and diabetes complications.
@nl
prefLabel
Mechanisms of disease: advance ...... on and diabetes complications.
@en
Mechanisms of disease: advance ...... on and diabetes complications.
@nl
P2093
P356
P1476
Mechanisms of disease: advance ...... on and diabetes complications.
@en
P2093
Ann Marie Schmidt
Ravichandran Ramasamy
Shi Fang Yan
P304
P356
10.1038/NCPENDMET0786
P577
2008-03-11T00:00:00Z